Ginkgo biloba extract VR456

highly standardized deterpened extract from Ginkgo biloba leaves

Also Known As:

VR456

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Hemorrhage 12/01/2010 - "These data point out the clear role played by the terpenoid, PAF-antagonist fraction of Ginkgo biloba extract in affecting bleeding risk in anticoagulant-treated subjects and suggest VR456 as a possible option treatment in geriatric people subjected to anticoagulant treatment where the use of standard Ginkgo biloba extracts are discouraged."